IMDA/NUI Galway Collaboration Explores Ways to Enhance Operational Efficiency
Tuesday, 2 March 2010
The Irish Medical Devices Association (IMDA), a business sector within IBEC, and NUI Galway's Applied Optics group, today hosted a seminar that focused the practical ways that optics can deliver scientific and technology solutions that enhance medical technology industry operations in Ireland. Speaking at the seminar, Sharon Higgins, director of IMDA said: "The medical technology sector in Ireland continues to grow. Exports of medical device and diagnostic products during the first three quarters of 2009 increased by more than 14% over the same period in 2008. This confirms Ireland as the second largest exporter of medical products in Europe, second only to Germany. The sector employs over 24,000 people, the highest per capita in Europe. Companies have adapted very successfully to changing economic circumstances, enhancing all aspects of their business models from R&D to manufacturing and commercialisation. "Our ability to engage with the academic and clinical community is critical to future growth. This collaboration with NUI Galway's Applied Optics group in developing today s programme will undoubtedly provide industry with opportunities to develop new ideas and contacts for the future." Keynote speaker at the event, Dr Alexander Knitsch, senior manager of international sales at TRUMPF Laser -und Systemtechnik GmbH Germany, applauded the IMDA and NUI Galway for their partnership. He said: "Optics is one of the key enabling technologies used to enhance medical device manufacturing and quality assurance processes. Ireland has a strong industry cluster and an internationally renowned optics group in NUI Galway. Together, I have no doubt that they will lead in adapting and developing these technologies to significantly enhance efficiencies." Dr James J. Browne, President of NUI Galway, welcomed the opportunity to engage with industry, saying: "Our Applied Optics group focuses on addressing the needs of industry and transferring research outcomes from the lab bench to the market."